삼성서울병원

Ko En

혈액종양내과 박세훈 교수

진료분야
폐암, 식도암
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2020.09 성균관대학교 의과대학 박사학위 취득
2016.02 서울대학교 의과대학 석사학위 취득
2009.02 서울대학교 의과대학 졸업

경력

경력
2022.03 ~현재 삼성서울병원 혈액종양내과 조교수
2019.12 ~ 2022.02 삼성서울병원 혈액종양내과 임상조교수
2017.12 ~ 2019.11 삼성서울병원 혈액종양내과 임상강사
2016.06 ~ 2017.11 Roche/Genentech
2012.03 ~ 2016.02 서울대학교병원 내과 레지던트 수료
2011.03 ~ 2012.02 서울대학교병원 인턴 수료

학회활동

학회활동
대한내과학회 회원
대한암학회 회원
대한폐암학회 회원
미국암연구학회(AACR) 회원
미국임상암학회(ASCO) 회원
세계폐암학회(IASLC) 회원

수상이력

수상이력
2021.11 보건의료기술진흥 유공자 정부포상 장관표창
  • Mol Cancer Res / 2020.09.30 Clinical characteristics and exploratory genomic analyses of germline BRCA1 or BRCA2 mutations in breast cancer Sehhoon Park 1, Eunjin Lee , Seri Park , Sohee Lee , Seok Jin Nam , Seok Won Kim , Jeong Eon Lee , Jong-Han Yu , Ji-Yeon Kim , Jin Seok Ahn , Young-Hyuck Im , Woong-Yang Park , Kyunghee Park , Yeon Hee Park
    View PubMed
  • Expert Opin Pharmacother / 2020.11.30 Evaluating entrectinib as a treatment option for non-small cell lung cancer Jiyun Lee 1, Sehhoon Park , Hyun Ae Jung , Jong-Mu Sun , Se-Hoon Lee , Jin Seok Ahn , Keunchil Park , Myung-Ju Ahn
    View PubMed
  • J Neurooncol / 2020.09.30 Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR Minjung Seong 1, Sehhoon Park , Sung Tae Kim , Sung Goo Park , Yi Kyung Kim , Hyung-Jin Kim , Myung-Ju Ahn
    View PubMed
  • Cancer Res Treat / 2020.10.31 EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation Sehhoon Park 1, Bo Mi Ku , Hyun Ae Jung , Jong-Mu Sun , Jin Seok Ahn , Se-Hoon Lee , Keunchil Park , Myung-Ju Ahn
    View PubMed
  • Cancer / 2020.09.01 Biomarker?driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum?based chemotherapy Sehhoon Park 1, Joonho Shim , Peter G S Mortimer , Simon A Smith , Robert E Godin , Simon J Hollingsworth , Hee-Jung Kim , Hyun Ae Jung , Jong-Mu Sun , Woong-Yang Park , Jin Seok Ahn , Myung-Ju Ahn , Se-Hoon Lee , Keunchil Park
    View PubMed
  • Ann Oncol / 2020.10.31 A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy S Park 1, M-H Lee , M Seong , S T Kim , J-H Kang , B C Cho , K H Lee , E K Cho , J-M Sun , S-H Lee , J S Ahn , K Park , M-J Ahn
    View PubMed
  • ANN ONCOL 2020 10.1016/j.annonc.2020.08.2234 Osimertinib in central nervous system progressive EGFR-mutant lung cancer do we need to detect T790M? Park1, S; Ahn, MJ
    View PubMed
  • J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status Lee1, J; Choi, YL; Han, J; Park, S; Jung, HA; Su, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • BIOLOGY-BASEL 2020 10.3390/biology9100326 Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations Are They Different from Those with Common EGFR Mutations? Jung1, HA; Park, S; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Park, K
    View PubMed
  • ANN ONCOL 2020 10.1016/j.annonc.2020.06.017 A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy Park1, S; Lee, MH; Seong, M; Kim, ST; Kang, JH; Cho, BC; Lee, KH; Cho, EK; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2020.278 EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation Park1, S; Ku, BM; Jung, HA; Sun, JM; Ahn, JS; Lee, SH; Park, K; Ahn, MJ
    View PubMed
  • J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity Hong1, TH; Cha, H; Shim, JH; Lee, B; Chung, J; Lee, C; Kim, NKD; Choi, YL; Hwang, S; Lee, Y; Park, S; Jung, HA; Kim, JY; Park, YH; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH; Park, WY
    View PubMed
  • J NEURO-ONCOL 2020 10.1007/s11060-020-03617-2 Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal added value of contrast-enhanced 2D axial T2 FLAIR Seong1, M; Park, S; Kim, ST; Park, SG; Kim, YK; Kim, HJ; Ahn, MJ
    View PubMed
  • MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-1108 Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer Park1, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH
    View PubMed
  • CANCER 2020 10.1002/cncr.33048 Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy Park1, S; Shim, J; Mortimer, PGS; Smith, SA; Godin, RE; Hollingsworth, SJ; Kim, HJ; Jung, HA; Sun, JM; Park, WY; Ahn, JS; Ahn, MJ; Lee, SH; Park, K
    View PubMed
  • EXPERT OPIN PHARMACO 2020 10.1080/14656566.2020.1798932 Evaluating entrectinib as a treatment option for non-small cell lung cancer Lee1, JY; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • J Thorac Oncol / 2019.12.31 In Reply: DDR Pathway Alteration, Tumor Mutation Burden and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole-Exome and Targeted-Gene Sequencing. Sehhoon Park 1, Se-Hoon Lee , Keunchil Park
    View PubMed
  • AACR / 2019년 Clinical characteristics and combined somatic mutation using target sequencing among breast cancer patients with germline BRCA mutation Park Sehhoon1, Lee Eunjin, Park Seri, Lee Sohee, Hur Joon Young, Yoon Sang Eun, Lee Kangkook, Cho Jang Ho, Kim Ji-Yeon, Ahn Jin Seok
  • J Thorac Oncol / 2019.09.30 DNA damage response and repair pathway alteration and its association with tumor mutation burden and platinum-based chemotherapy in SCLC Sehhoon Park 1, Hayoon Lee , Boram Lee , Se-Hoon Lee , Jong-Mu Sun , Woong-Yang Park , Jin Seok Ahn , Myung-Ju Ahn , Keunchil Park
    View PubMed
  • Lung Cancer / 2019.01.31 Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor Sehhoon Park 1, Joungho Han , Jong-Mu Sun
    View PubMed
  • Lung Cancer / 2018.10.31 Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial Sung Won Lim 1, Sehhoon Park , Youjin Kim , Jang Ho Cho , Song Ee Park , Hansang Lee , Hee Kyung Kim , Sung Min Kim , Jong Mu Sun , Se-Hoon Lee , Jin Seok Ahn , Keunchil Park , Myung-Ju Ahn
    View PubMed
  • J Thorac Oncol /2018.06.05 Characteristics and outcome of ROS1-positive non?small cell lung cancer patients in routine clinical practice Sehhoon Park 1, Beung-Chul Ahn , Sung Won Lim , Jong-Mu Sun , Hye Ryun Kim , Min Hee Hong , Se-Hoon Lee , Jin Seok Ahn , Keunchil Park , Yoon La Choi , Byoung Chul Cho , Myung-Ju Ahn
    View PubMed
  • PLoS One / 2018.01.31 Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor Sehhoon Park 1, Seunggyun Ha , Se-Hoon Lee , Jin Chul Paeng , Bhumsuk Keam , Tae Min Kim , Dong-Wan Kim , Dae Seog Heo
    View PubMed
  • Korean J Intern Med / 2017.04.14 KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer Sehhoon Park 1, Ji-Yeon Kim , Se-Hoon Lee , Beomseok Suh , Bhumsuk Keam , Tae Min Kim , Dong-Wan Kim , Dae Seog Heo
    View PubMed
  • Ann Oncol / 2017.04.01 Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma J-K Lee 1, S Louzada , Y An , S Y Kim , S Kim , J Youk , S Park , S H Koo , B Keam , Y K Jeon , J-L Ku , F Yang , T M Kim , Y S Ju
    View PubMed
  • BMC Cancer / 2017.05.15 Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma Yeonghun Lee 1, Sehhoon Park , Se-Hoon Lee , Hyunju Lee
    View PubMed
  • Atherosclerosis / 2016.02.28 Early repolarization is associated with significant coronary artery stenosis in asymptomatic adults Beomseok Suh 1, Sehhoon Park , Dong Wook Shin , Hongkeun Ahn , Seongcheol Cho , Seung-Pyo Lee , Eun-Ah Park , Hyejin Lee , Jin Ho Park , BeLong Cho
    View PubMed
  • Medicine (Baltimore) / 2016.01.31 Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome Sehhoon Park 1, Hwi Young Kim, Haeryoung Kim, Jin Hyun Park, Jung Ho Kim, Ki Hwan Kim, Won Kim, In Sil Choi, Yong Jin Jung, Jin-Soo Kim
    View PubMed
  • Tuberc Respir Dis (Seoul) / 2015.06.30 A case of statin-induced interstitial pneumonitis due to rosuvastatin Se Yong Kim 1, Se Jin Kim , Doran Yoon , Seung Wook Hong , Sehhoon Park , Chan-Young Ock
    View PubMed
  • Hepatology / 2015.02.13 High liver fibrosis index FIB?4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers Beomseok Suh 1, Sehhoon Park, Dong Wook Shin, Jae Moon Yun, Hyung-Kook Yang, Su Jong Yu, Cheong-Il Shin, Jin-Soo Kim, Eunmi Ahn, Hyejin Lee, Jin Ho Park, BeLong Cho
    View PubMed

해당하는 결과가 없습니다.